Xiaoteng Cui

1.6k citations

44 papers · 1.1k · h-index 21

Impact in

Genetics top 5%
- Glioma Diagnosis and Treatment
Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics

Papers in

Genetics 17
- Glioma Diagnosis and Treatment 17
Cancer Research 12
- Cancer-related molecular mechanisms research 5
- Cancer, Hypoxia, and Metabolism 3
- Cancer Genomics and Diagnostics 3

Co-authors: Chunsheng Kang (26 shared papers)Qixue Wang (19 shared papers)Yanli Tan (11 shared papers)Chuan Fang (10 shared papers)Jie Yang (13 shared papers)Yunfei Wang (12 shared papers)Shixue Yang (11 shared papers)Kaikai Yi (9 shared papers)
Journals: Neuro-Oncology (7 papers)Theranostics (4 papers)Frontiers in Oncology (2 papers)Cell Death and Disease (2 papers)RNA Biology (2 papers)
Partner nations: China Canada United States

In The Last Decade

Xiaoteng Cui

41 papers receiving 1.1k citations

Peers

Countries citing papers authored by Xiaoteng Cui

Since Specialization

Citations

This map shows the geographic impact of Xiaoteng Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoteng Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoteng Cui more than expected).

Fields of papers citing papers by Xiaoteng Cui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoteng Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoteng Cui. The network helps show where Xiaoteng Cui may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiaoteng Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaoteng Cui Line = papers co-authored together Xiaoteng Cui links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	A pan-cancer analysis of the oncogenic role of staphylococcal nuclease domain-containing protein 1 (SND1) in human tumors Genomics ·Xiaoteng Cui, Xinxin Zhang, Minghui Liu, Chunyan Zhao, Nan Zhang, Yuanyuan Ren, Chao Su, Wei Zhang	2020	116
2	Blood exosomes-based targeted delivery of cPLA2 siRNA and metformin to modulate glioblastoma energy metabolism for tailoring personalized therapy Neuro-Oncology ·Qi Zhan, Kaikai Yi, Xiaoteng Cui, Xueping Li, Shixue Yang, Qixue Wang, Chuan Fang, Yanli Tan	2022	97
3	RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGFβ pathway-dependent manner Cell Death and Disease ·Kai Zhao, Xiaoteng Cui, Qixue Wang, Chuan Fang, Yanli Tan, Yunfei Wang, Kaikai Yi, Chao Yang	2019	59
4	Phosphatidylcholine‐Engineered Exosomes for Enhanced Tumor Cell Uptake and Intracellular Antitumor Drug Delivery Macromolecular Bioscience ·Qi Zhan, Kaikai Yi, Xueping Li, Xiaoteng Cui, Eryan Yang, Ning Chen, Xubo Yuan, Jin Zhao	2021	58
5	A novel compound EPIC-0412 reverses temozolomide resistance via inhibiting DNA repair/MGMT in glioblastoma Neuro-Oncology ·Jixing Zhao, Shixue Yang, Xiaoteng Cui, Qixue Wang, Eryan Yang, Fei Tong, Biao Hong, Menglin Xiao	2022	54
6	LncRNA PRADX-mediated recruitment of PRC2/DDX5 complex suppresses UBXN1 expression and activates NF-κB activity, promoting tumorigenesis Theranostics ·Yansheng Li, Xing Liu, Xiaoteng Cui, Yanli Tan, Qixue Wang, Yunfei Wang, Can Xu, Chuan Fang	2021	49
7	TCA-phospholipid-glycolysis targeted triple therapy effectively suppresses ATP production and tumor growth in glioblastoma Theranostics ·Shixue Yang, Jixing Zhao, Xiaoteng Cui, Qi Zhan, Kaikai Yi, Qixue Wang, Menglin Xiao, Yanli Tan	2022	47
8	SND1 acts as an anti-apoptotic factor via regulating the expression of lncRNA UCA1 in hepatocellular carcinoma RNA Biology ·Xiaoteng Cui, Chunyan Zhao, Xuyang Yao, Baoxin Qian, Yuanyuan Ren, Zhi Yao, Xingjie Gao, Jie Yang +1 other	2018	42
9	Oncoprotein SND1 hijacks nascent MHC-I heavy chain to ER-associated degradation, leading to impaired CD8 + T cell response in tumor Science Advances ·Yuan Wang, Xinting Wang, Xiaoteng Cui, Yue Zhuo, Hongshuai Li, Chuanbo Ha, Lingbiao Xin, Yuanyuan Ren	2020	41
10	HIF1α/ATF3 partake in PGK1 K191/K192 succinylation by modulating P4HA1/succinate signaling in glioblastoma Neuro-Oncology ·Shixue Yang, Qi Zhan, Dongyuan Su, Xiaoteng Cui, Jixing Zhao, Qixue Wang, Biao Hong, Jiasheng Ju	2024	41
11	Poly(A)+ mRNA‐binding protein Tudor‐SN regulates stress granules aggregation dynamics FEBS Journal ·Xingjie Gao, Xue Fu, Juan Song, Yi Zhang, Xiaoteng Cui, Chao Su, Lin Ge, Jie Shao	2015	37
12	Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma 癌症：英文版 ·Xiaoteng Cui, Jixing Zhao, Guanzhang Li, Chao Yang, Shixue Yang, Qi Zhan, Junhu Zhou, Yunfei Wang	2023	37
13	PTRF/Cavin-1 enhances chemo-resistance and promotes temozolomide efflux through extracellular vesicles in glioblastoma Theranostics ·Eryan Yang, Weili Jin, Xing Liu, Qixue Wang, Ye Wu, Yanli Tan, Yunfei Wang, Xiaoteng Cui	2022	34
14	Phosphorylation of Tudor-SN, a novel substrate of JNK, is involved in the efficient recruitment of Tudor-SN into stress granules Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Chao Su, Xingjie Gao, Wendong Yang, Yali Zhao, Xue Fu, Xiaoteng Cui, Chunyan Zhang, Lingbiao Xin	2016	33
15	Single-Cell Transcriptomics of Glioblastoma Reveals a Unique Tumor Microenvironment and Potential Immunotherapeutic Target Against Tumor-Associated Macrophage Frontiers in Oncology ·Xiaoteng Cui, Qixue Wang, Junhu Zhou, Yunfei Wang, Can Xu, Hongjun Wang, Chunsheng Kang +1 other	2021	31
16	PTRF/Cavin-1 as a Novel RNA-Binding Protein Expedites the NF-κB/PD-L1 Axis by Stabilizing lncRNA NEAT1, Contributing to Tumorigenesis and Immune Evasion in Glioblastoma Frontiers in Immunology ·Kaikai Yi, Xiaoteng Cui, Xing Liu, Yunfei Wang, Jixing Zhao, Shixue Yang, Can Xu, Eryan Yang	2022	31
17	CRISPR-Cas9 library screening combined with an exosome-targeted delivery system addresses tumorigenesis/TMZ resistance in the mesenchymal subtype of glioblastoma Theranostics ·Jixing Zhao, Xiaoteng Cui, Qi Zhang, Kailiang Zhang, Dongyuan Su, Shixue Yang, Biao Hong, Qixue Wang	2024	31
18	MUC1 promotes glioblastoma progression and TMZ resistance by stabilizing EGFRvIII Pharmacological Research ·Jixing Zhao, Zi-yuan Fang, Xiaoteng Cui, Dongyuan Su, Xing Liu, Junhu Zhou, Guangxiu Wang, Shizhong Liu	2022	28
19	Growth arrest–specific 2 protein family: Structure and function Cell Proliferation ·Nan Zhang, Chunyan Zhao, Xinxin Zhang, Xiaoteng Cui, Yan Zhao, Jie Yang, Xingjie Gao	2020	23
20	RUNX1/NPM1/H3K4me3 complex contributes to extracellular matrix remodeling via enhancing FOSL2 transcriptional activation in glioblastoma Cell Death and Disease ·Xiaoteng Cui, Dawei Huo, Qixue Wang, Yunfei Wang, Xiaomin Liu, Kai Zhao, Yongping You, Junxia Zhang	2024	22

About Xiaoteng Cui

Xiaoteng Cui is a scholar working on Genetics, Cancer Research, Cell Biology, Oncology and Molecular Biology, having authored 44 papers that have together received 1.1k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (17 papers), Cancer-related molecular mechanisms research (5 papers), Cancer, Hypoxia, and Metabolism (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cancer Genomics and Diagnostics (3 papers), Endoplasmic Reticulum Stress and Disease (2 papers), RNA Research and Splicing (2 papers) and Extracellular vesicles in disease (2 papers). The work is most often cited by research in Genetics (245 citations), Cancer Research (287 citations), Oncology (141 citations), Molecular Biology (397 citations) and Biomaterials (39 citations). Xiaoteng Cui has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Chunsheng Kang, Qixue Wang, Yanli Tan, Chuan Fang, Jie Yang, Yunfei Wang, Shixue Yang, Kaikai Yi, Xingjie Gao and Can Xu. Their work appears in journals such as Neuro-Oncology, Theranostics, Frontiers in Oncology, Cell Death and Disease and RNA Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Xiaoteng Cui

Impact in

Papers in i

In The Last Decade

Xiaoteng Cui

Peers

Countries citing papers authored by Xiaoteng Cui

Fields of papers citing papers by Xiaoteng Cui

All Works

About Xiaoteng Cui

Explore authors with similar magnitude of impact

Papers in